Pfizer's SBLA For 20vPnC Vaccine In Infants And Children Accepted By FDA For Priority Review
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced Friday that the U.S. Food and Drug Administration accepted for priority review a supplemental Biologics License Application or sBLA for its